Abstract Pulmonary vascular remodeling is the key structural alteration in pulmonary hypertension and involves changes in the intima, media and adventitia, often with the interplay of inflammatory cells. This review examines the pathology of these changes and highlights some of the pathogenetic mechanisms that underlie the remodeling process.
Introduction
Pulmonary hypertension (PH) refers to hemodynamic alterations of the pulmonary circulation in which the pulmonary artery pressures are in excess of 25 mmHg -largely the result of the ground breaking introduction of pulmonary catheterization in the late 1940s (Fishman 1997) . In this setting, the pulmonary arteries and veins undergo several structural alterations that have been recognized as Bpulmonary vascular remodeling^. These structural alterations, although similar when recognized (and quantified) in pathological specimens, are probably heterogeneous molecularly. Pulmonary vascular remodeling is the result of and probably contributes to increased pulmonary vascular pressures by increasing pulmonary vascular resistance.
The pathology of PH has been summarized in all five international meetings held thus far, which have primarily targeted the classification of the disease, the direction of treatment and diagnostic algorithms. Pulmonary vascular pathology most strongly influenced the first international PH conference in 1973, reflecting the contributions of several outstanding pathologists dedicated to studying the disease, such as Wagenvoort, Reid, Edwards and Heath (Heath and Wagenvoort 1975 ). The conferences that followed (Evian, France, in 1998, see Haworth et al. 1998; Venice, Italy, in 2003 , see Pietra et al. 2004 Dana Point, USA, in 2008 and Nice, France in 2013, see Simonneau et al. 2004 Simonneau et al. , 2013 , while recognizing the relevance of the pathology of pulmonary vascular remodeling, largely restricted its description as a means to a better understanding of the pathobiology of the disease (Tuder et al. 2013a ). The present classification, formulated in Nice, France (Simonneau et al. 2013) , is widely used to guide investigators in the field.
In prior reviews (Tuder and Erzurum 2009 ), chose to segment PH with regard to the levels of pulmonary artery pressures; mild to moderate, when in between 25 and 45 mmHg and severe, when in excess of 45-50 mmHg. We acknowledge that this categorization is largely arbitrary but, in our experience, it underscores that severe disease shares some distinct structural alterations of hypertensive pulmonary arteries, many of which are irreversible. This two-level characterization of PH reflects with reasonable accuracy the overall impact of PH on the right ventricle; right ventricular failure is ultimately the trigger of a patient's demise and of physiological impairment.
However, to appreciate fully the clinical and research importance of pulmonary vascular remodeling, an examination of the intricate relationship between normal pulmonary arterial physiology and macro-and micro-anatomy is imperative. In a recent review, we summarized several important aspects of normal pulmonary vascular structure, bringing to light anatomical and structural insights (which are now more than 50 years old) with a handful of three-dimensional casting studies in animals and (some) humans (Tuder et al. 2013b) . A single right ventricular beat normally propels approximately 500 ml of stroke blood volume into the pulmonary arterial system, with approximately 140 ml of blood in 277 billion capillaries (or about 10^11), occupying the equivalent of a tennis-court-sized pulmonary gas-exchange area. This extensive capillary network is supplied by 10^8 pulmonary vascular segments of 15-40 μm in diameter. A key characteristic of PH is the loss of a well-defined pulmonary vascular media composed of smooth muscle cells in arteries smaller than 70 μm in diameter: this structural characteristic might be teleologically critical to the requirement to be perfused at low pressures, a distinguishing feature of the pulmonary circulation vis-à-vis the systemic circulation.
Given the critical requirement to have low capillary perfusion pressures for optimal gas exchange, one can envision the need for pulmonary vascular remodeling as a means to dissipate (more) proximally (than the capillary bed) high pulmonary pressures. Where are these high pressures generated in an acutely hypoxic normal lung, such as during acute hypoxia (fraction of inspired O 2 in air of less than 13 %)? The property of hypoxic pulmonary vasoconstriction (HPV) resides in specialized pulmonary smooth muscle cells (McMurtry et al. 1976) , which can depolarize under alveolar hypoxia and have a surge of intracytoplasmic calcium (Sylvester et al. 2012) . HPV appears to occur in arteries as large as 1.2 mm in the dog; subsequent studies have outlined that HPV will occur in arteries of less than 50 μm in diameter (in the dog) and approximately 80 μm in the sheep (Sylvester et al. 2012 ). Interestingly, this wide range of arterial diameters includes those arterial segments that undergo pulmonary vascular remodeling in PH. Therefore, the combined effects of excessive vasoconstriction and of cell autonomous growth (combined with lack of cell death) might ultimately account for the structural alterations of the pulmonary circulation in PH (Tuder et al. 2013b) .
Chronic exposure to hypoxia (usually modeled by exposing animals to a fraction of inspired oxygen (FiO2) of 50 % or 8900 m) causes hypoxic PH. Because of HPV and/or the superimposed release of growth factors, pulmonary arteries undergo excessive muscularization, with a predominance of media remodeling but with no or minimal intima remodeling. Whereas the way that the pulmonary artery is remodeled under chronic hypoxia remains under debate, it is a valuable disease-related process as it may be related to PH in association with hypoxic states, such as those at high altitude and during chronic obstructive pulmonary disease (COPD). However, hypoxic PH is largely of mild to moderate severity (see above).
In this review, we describe the spectrum of pulmonary vascular remodeling in PH, particularly of the Group 1 disease, also named pulmonary arterial hypertension (PAH; Simonneau et al. 2013) ; moreover, we extend these insights into (some) small animal models. We briefly outline approaches to quantify key structural/morphological alterations and the potential impact of these features (also referred to as pulmonary vascular lesions; Pietra et al. 2004 ) in disease pathogenesis and pulmonary arterial pressures. This discussion is framed within the macroscopic and microscopic pulmonary vascular compartments of the intima lined by endothelial cells, the media composed largely of smooth muscle cells and the adventitia populated by fibroblasts and, in PH, by inflammatory cells. Readers are encouraged to complement their present perusal with comprehensive reviews on the pathobiology of PH (Archer et al. 2010; Schermuly et al. 2011; Tuder et al. 2013a ).
Pulmonary vascular remodeling in PH Intima remodeling
The intima represents an endothelial cell-thick interface between the muscular media and the flowing blood. In the pulmonary circulation, the intima provides a vast surface area of unobstructed flow and therefore contributes to relatively low perfusion pressures, which is the trademark of the pulmonary circulation. Indeed, the combined intima surface area of pulmonary arteries in the range of 20-30 μm in diameter is of 2-3 log that of more proximal pulmonary arterial segments (Tuder et al. 2013b) .
The extent that the intima is compromised in PH is unknown. In a recent study, we demonstrated that, based on cross-sections of pulmonary arteries, normal intima represents approximately 10 % of the overall thickness; these findings are in agreement with prior studies of the pathology of idiopathic pulmonary arterial hypertension (IPAH), the paradigmatic example of severe PH (Chazova et al. 1995) ; in severe disease, lungs with PAH show an approximately 3-fold increase in intima fractional thickness (Stacher et al. 2012) . Of note, this thickened intima will result in an approximately 1.5^4 (40-fold) increase in pulmonary vascular resistance. Interestingly, by using the parameter of volume density with alveolar septa as a reference, a doubling of PAH vs. control intima occurs, which is overall within the range seen with another quantitative approach, namely of the measurement of intima fractional thickness (Stacher et al. 2012) .
Interestingly, approximately 25 % of lungs with PAH have intima thickening that overlaps the values seen in controls (normal lungs; Stacher et al. 2012) . As noted below, the overlap between media and adventitia fractional thickness between control and PAH pulmonary arteries is more pronounced than that seen for the intima alone.
The types of intima thickening are varied. They can be briefly summarized as being based on the predominance of collagen and mucin, fibroblastic-like cells, or endothelial cells (Fig. 1e) . Endothelial-like cells, when proliferated in a disorganized fashion, form plexiform lesions (Fig. 1b, d ; Tuder and Zaiman 2004) . These are glomeruloid-like lesions, with variable formation of incipient blood vessels. Our prior studies demonstrated the expression of markers of angiogenesis in these lesions , including vascular endothelial growth factor (VEGF), VEGF receptors and hypoxia inducible factor (HIF)-1α. Although its pathogenesis remains unclear, lesion formation is often seen in severe Group 1 PAH and in Group 2 with PH associated with congenital heart malformations. Plexiform lesions are characteristic of IPAH morphology; moreover, they can be found in a significant number of cases of associated PAH (APAH, usually in the setting of collagen vascular diseases; Stacher et al. 2012) . We have detected plexiform lesions in 90 % of lungs with PAH. A large variation of plexiform lesion profiles exists in a given lung and among PAH lungs; although it is tempting to speculate that plexiform lesions are the forerunners of occlusive intima lesions, no such correlation has been observed (Stacher et al. 2012) .
Obliterative concentric lesions are characterized by an onion-skin arrangement of endothelial and/or smooth muscle cells (Fig. 1d) . These lesions appear to be completely restricted to the pulmonary vascular lumen. Both plexiform and concentric lesions have been linked to IPAH (Heath and Edwards 1958) ; we have confirmed the geographical association of concentric and plexiform lesion, with the former being present proximally to plexiform lesions, based on three-dimensional reconstruction studies (Cool et al. 1999) .
Additional intima lesions consist in lesions characterized by being paucicellular, with an increase in connective tissue, including extracellular matrix. Many lesions appear to contain excessive amounts of mucopolysaccharides. The way that these lesions develop and their overall fate remain unclear; they have been probably referenced as intima fibrosis in prior pathological descriptions of PH.
Interestingly, the intima fractional thickness, a measure of the extent of the contribution of the pulmonary artery intima to the overall diameter, is significantly higher in IPAH pulmonary arteries when compared with those in APAH. Moreover, this index is also higher in the lungs of patients with documented mutations in bone morphogenetic protein receptor 2 (BMPR2) when compared with those with no identifiable mutations (Stacher et al. 2012) . These novel findings appear to correlate with the clinical findings of more severe disease in patients with BMPR2 mutations and PAH.
Media remodeling
The media, which is composed predominantly of smooth muscle cells, has been the focus of prior pathological descriptions and pathophysiological studies in PH. Probably because of the properties of mediating HPV and the prominence of media remodeling in PH attributable to chronic hypoxia, the study of PAH has largely been focused on the smooth muscle cell of the media.
Prior studies have shown that normal media thickness corresponds to approximately 5 % (or less) of the overall pulmonary artery diameter (Chazova et al. 1995) . Our data indicate that control lungs, largely obtained from the accidental death of younger adults, exhibit media fractional thickness of approximately 20 % (Stacher et al. 2012 ). The increase in PAH is approximately 20 % over that of control lungs. Remarkably, we found a significant overlap of media fractional thickness between 60 % of the lungs of patients with PAH and control values (Stacher et al. 2012) . These findings are of interest; they may reflect true differences between the control population or sampling differences that may justify the observed differences. Moreover, if a significant degree of shared medial pulmonary artery thickness indeed occurs between control lungs and those with severe PAH, then functional alterations become critical to an explanation of the way that media remodeling contributes to the disease.
Of interest, the parameter of combined intima and media thickness correlates significantly with pulmonary artery pressures and pulmonary resistance. These findings might appear predictable, as with increased pulmonary artery pressures and pulmonary vascular resistance, an associated heightened media (and intima) remodeling occurs (notwithstanding the degree of overlap with media thickness with control lungs). On the other hand, this finding also supports the hypothesis that the combined remodeling of both the intima and the media plays a role in the pathogenesis of PH.
Adventitia remodeling
The remodeling of the adventitia was one of the most prominent findings reported in an autopsy series of 19 patients with IPAH (Chazova et al. 1995) . This study reported an increase in adventitia thickness of approximately 2-to 4-fold in IPAH lungs vs. controls. Similar prominent adventitia remodeling was noted in cows with Brisket's disease (enhanced susceptibility to severe PH and right ventricular failure attributable to grazing at high altitude; Newman et al. 2011) and in cows exposed to chronic hypoxia (simulated altitude of 17,000 ft [5181.6 m], i.e., FiO2 of 10 %; Davie et al. 2006) .
Our data however do not indicate that remodeled pulmonary arteries have more advanced adventitia remodeling than controls (with 98 % of patients with PAH overlapping with controls; Stacher et al. 2012) . However, methodological limitations possibly hamper the measurement of adventitia remodeling. The unclear boundaries of the adventitia impose a challenge for their precise demarcation (at least in the human lung) and therefore introduce significant pitfalls for analyses; the adventitia is largely composed of a connective tissue sheath that surrounds the airways and pulmonary arteries. It contains lymphatic vessels and is the conduit of inflammation, either targeted at airways (as in bronchiolitis or asthma) or directed at pulmonary arteries (as in PH).
Notwithstanding the difficulties in analyzing the extent of adventitia remodeling in PH, substantial evidence has been presented that the adventitia plays key roles as an inflammatory cell signaling hub (Pugliese et al. 2015; Stenmark et al. 2015) . It acts as a signaling hub by holding feed-forward interactions between resident fibroblasts and incoming macrophages. Moreover, the adventitia might act as a reservoir for bone-marrow-derived progenitors that might directly or indirectly stimulate pulmonary vascular remodeling (Majka et al. 2008) .
Perivascular inflammation
Given the prominence of pulmonary vascular remodeling, the component of inflammation remained largely on the side lines during the first more detailed descriptions of pulmonary vascular remodeling in PH (Bjornsson and Edwards 1985; Heath and Edwards 1958) . However, interest has grown in the findings, characterization and functional studies of the role of inflammation in PH (Fig. 1f) .
The presence of macrophages and lymphocytes was highlighted in the early 1990s , suggesting that they participate in the process of pulmonary vascular remodeling. Mast cells were recognized as participants of the structural findings in PAH (Caslin et al. 1990) , as confirmed in more recent studies (Savai et al. 2012 ).
In addition, perivascular remodeling was semiquantitatively assessed and shown to correlate with hemodynamic parameters in PAH (Stacher et al. 2012 ); despite attempts to employ volume density with alveolar septa as the reference tissue, a semi-quantitative grading ranging from 0 (absent) to 3 (abundant) was used to generate an inflammatory score. Of note, there was a correlation noted between the perivascular inflammation score and the intima + media fractional thickness and a strong correlational trend existed with pulmonary artery pressures.
These studies were further extended to improve the characterization of the types of inflammatory cells occurring in PAH lungs (Savai et al. 2012 ). The study confirmed that CD68+ macrophages, CD14+ monocytes and dendritic cells accumulated in the adventitia of remodeled pulmonary arteries in IPAH. Increases occurred in all T lymphocyte populations, with a decreased number of FoxP3 cells being noted in IPAH lungs vs. controls.
However, inflammation involves more than just the presence of inflammatory cells around remodeled pulmonary arteries in PH. Cytokines and chemokines are clearly drivers and contributors to perivascular inflammation in PH. Interleukin-1 (IL-1) was recognized as a mediator of monocrotaline-induced rodent PH in the 1990s ), a result that was supported by observations in samples of patients with PAH (Humbert et al. 1995) . These early observations led to a large set of new data linking inflammation to the pathobiology of PAH (Dorfmuller et al. 2003; Hassoun et al. 2009; Soon et al. 2010) , some of which revealed a strong correlation with the severity of disease (notably IL-6, IL-8, IL-20 and IL-12; Soon et al. 2010) . Schistosomiasis-induced PAH is perhaps a paradigmatic entity in which a parasite, Schistosoma mansoni, triggers a TH-2 dominant response (Graham et al. 2010 ) and pulmonary vascular lesions identical to those seen in idiopathic PAH. Experimentally, the TH-2 inflammation leads to increased transforming growth factor (TGF)-β1 (Kumar et al. 2015) , which ultimately trigger pulmonary artery remodeling and PH. This process is largely dependent on thrombospondin-1-producing blood marrow monocytes (R. Kumar et al., unpublished) . All these data support not only that inflammation is part of the pathology of PH but also that it may indeed drive several of the key pulmonary vascular lesions characteristic of the disease.
Other pathological alterations present in PH
Old and recent clots are among the pathological alterations seen in PH lungs. They were reported in prior pathological assessments of the pulmonary circulation in PH (Palevsky et al. 1989 ), a condition largely called thromboembolic primary PH. However, this study reported significant thrombi in the group of patients having Barteriopathy with plexiform lesions^. We confirmed these findings in our series, with a 50 % detection of clots in remodeled pulmonary arteries (Stacher et al. 2012) ; a large number of these patients (42 %) were receiving anti-coagulation treatment.
Although some unusual pathological findings can occur in lungs with PAH, including areas of alveolar exudates, granulomas and peribronchiolar inflammation, they are incidental and probably reflect underlying alternative diseases or exposures, unrelated to PH.
How to analyze pulmonary vascular remodeling in PH
Notwithstanding the important contributions made by detailed, largely qualitative, descriptions of pulmonary vascular remodeling in PH (in fact, mostly PAH; Bjornsson and Edwards 1985; Chazova et al. 1995; Heath and Edwards 1958; Pietra et al. 1989; Wagenvoort and Wagenvoort 1970) , a stringent quantitative assessment of the pathology of severe PH remains to be performed. Most of these prior studies are biased (i.e., contain analytical errors) because of inappropriate random and systematic sampling and the lack of assessment of key stereological parameters (such as assessments of surface area and length). As summarized in excellent reviews (Hsia et al. 2010; Hyde et al. 2006; Muhlfeld and Ochs 2013) , these approaches require a priori experimental planning and design and a knowledge of the fundamentals of stereology applied to organ samples. Indeed, many of the current concepts of stereology, while based on the seminal work of Weibel and collaborators (Weibel and Gomez 1962) , were developed in the last two decades and require proper knowledge and training. These have been largely absent in the approaches in the pulmonary vascular field.
Recently, we summarized the importance of stereological methods for the proper assessment of parameters of pulmonary vascular remodeling (Tuder 2014) . Unfortunately, most of the current endpoints, including the percent of fully, partially and nonmuscularized small, medium and large pulmonary arteries or the percent of occluded arteries, provide an unclear picture of pulmonary vascular remodeling because of errors (or biases) in their assessment. The parameter of the percent of media thickening, which in fact conveys the volume density of the media in relation to the overall arterial wall, is limited by the need of almost perfect cross-sections. In our prior work (Stacher et al. 2012) , we used the volume of the media and intima in relation to the volume of the alveolar septa. This approach allowed us to analyze pulmonary arteries independently of their orientation and of the degree of lung inflation; we rely on the evidence that, in PAH, no alveolar destruction with emphysema is apparent. However, this assessment is limited by the lack of the uniform random sampling of the entire lung, i.e., the data pertain to fragments of lungs obtained from specific regions as per protocol design. We propose that the assessment of pulmonary vascular remodeling follows stereological rules (Muhlfeld and Ochs 2013) , which will therefore allow a better correlation with pulmonary hemodynamics. This approach will generate more robust and stringent data, permitting a better correlation with similar parameters obtained from human diseased samples. Moreover, it will provide better quality data regarding interventions that can attenuate or overcome specific components of pulmonary vascular remodeling in PH. These experimental advantages are particularly relevant to severe PAH, which is often modeled in rats that have received the VEGF receptor blocker SU 5416 and been exposed to chronic hypoxia . This model shares intima remodeling with concentric and plexiform-like lesions (Abe et al. 2010 ) with human PAH.
Conclusions
Few attempts have been made to properly quantify the pathological alterations in PAH lungs; this limitation also pertains to other forms of PH, including the highly frequent Group 3, associated with interstitial lung disease and COPD. Whereas the clinical advances in the diagnosis and management of PAH do not require pathological support, updates in the classification (including changes in subgrouping) often rely on pathology to cluster similar forms of the disease. The challenge remains to appropriately conduct stereological studies in lung with PAH; this will require systematic random sampling (Tuder 2014) .
